BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/26/2023 8:57:14 PM | Browse: 192 | Download: 640
 |
Received |
|
2023-02-25 06:50 |
|
Peer-Review Started |
|
2023-02-25 06:53 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-04-11 01:37 |
|
Revised |
|
2023-04-23 21:15 |
|
Second Decision |
|
2023-05-09 02:55 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-05-09 07:08 |
|
Articles in Press |
|
2023-05-09 07:08 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-05-12 09:49 |
|
Typeset the Manuscript |
|
2023-06-12 00:31 |
|
Publish the Manuscript Online |
|
2023-06-26 20:57 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Nivolumab-induced tumour-like gastritis: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Elena Cijauskaite, Edita Kazenaite, Sandra Strainiene, Benediktas Kurlinkus and Goda Sadauskaite |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sandra Strainiene, MD, Attending Doctor, Department of Internal Medicine and Surgery, Antakalnis Clinic, Antakalnis Street 59, Vilnius 10207, Lithuania. sandra.strainiene@gmail.com |
| Key Words |
Nivolumab; Immune checkpoint inhibitors; Tumour-like gastritis; Proton pump inhibitors; Case report |
| Core Tip |
Nivolumab-induced gastritis is a less common immune-related adverse event of nivolumab. The most common symptoms include nausea, pain, diarrhea, loss of appetite, and weight loss. Esophagogastroduodenoscopy and biopsy are the most important diagnostic tools. In most cases, gastritis is treated with corticosteroids in combination with proton pump inhibitors. In our case, the patient was successfully treated with omeprazole monotherapy. |
| Publish Date |
2023-06-26 20:57 |
| Citation |
Cijauskaite E, Kazenaite E, Strainiene S, Sadauskaite G, Kurlinkus B. Nivolumab-induced tumour-like gastritis: A case report. World J Clin Cases 2023; 11(18): 4350-4359 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i18/4350.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i18.4350 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
